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Factors of increase in serum triglyceride-rich lipoproteins in uremic
rats. The possible mechanisms of the increase in serum triglycerides
(TO) and TO-rich lipoproteins were studied in chronically uremic (U)
rats by comparison with either ad-lib fed control (C) rats or diet-
restricted (DR), sham-operated pair-fed control rats. A first series of
animals was studied in the fed state and a second series after a 16-hr
fast, In U animals the concentration of serum TO and TG-rich particles
was lower than that of C rats in the fed state but significantly higher than
that of C and DR rats after a 16-hr fast. Serum glucose and lactate
concentrations in the fed or fasted state were unchanged by uremia.
Serum insulin concentration was significantly decreased in U rats as
compared to C and DR rats in both series. The fast did not increase the
concentration of serum nonesterified fatty acids (NEFA) in U or DR
animals to the same extent as in C rats, whereas the serum concentra-
tion of /3-hydroxybutyrate (BOB), which was higher than that of C rats
in the fed state, was significantly lower after a 16-hr fast. In U animals,
as compared to control rats of either series, a significant decrease of
epididymal lipoprotein lipase (LPL) activity was observed during both
nutritional states when expressing the enzymic activity per number of
cells. In conclusion, our data provide evidence against hepatic over-
production of TG-rich lipoproteins in rats with chronic renal failure and
strongly point to an LPL-mediated defect of their peripheral catabo-
lism, probably related to the insulin deficiency state.
Les facteurs de l'augmentation dans lipoprotéines scriques riches en
triglycerides chez des rats en insuffisance rénale. Les mdcanismes
possibles de l'augmentation des triglycerides (TG) sCriques et des
lipoprotCines riches en TG ont Cté étudiés chez des rats en insuffisance
rénale chronique (U) en comparaison avec des rats tCmoins, soit nourris
ad libitum (C), soit recevant Ia méme quantitC de nourriture que les rats
U et ayant subi un simulacre d'operation (DR). Les animaux d'une
premiere série ont etC analyses a l'Ctat nourri et ceux d'une seconde
série après un jeUne de 16 hr. Chez les rats U Ia concentration sCrique
des TG et des particules riches en TG est plus faible que celle des rats
C a l'Ctat nourri alors qu'elle est significativement plus ClevCe que celle
des rats C et DR aprés un jefine de 16 hr. Les concentrations sCriques
de glucose et de lactate ne sont pas modifiCes par l'urCmie chronique
quel que soit l'Ctat de jeüne de l'Ctude. En revanche, les concentrations
sCriques d'insuline sont significativement diminuCes chez les rats U par
rapport aux rats C et DR dans les deux series expCnmentales. La
reponse au jeüne montre que les acides gras non estCrifies n'augmentent
pas autant chez les rats U et DR que chez les rats C. Chez les rats U,
la concentration serique de 13-hydroxybutyrate est plus ClevCe que celle
des rats C a l'Ctat nourri alors qu'elle est significativement plus faible
après un jeUne de 16 hr. Enfin, chez les animaux U, il existe une
diminution significative de l'activitC de Ia lipoprotCine lipase du tissu
adipeux epididymaire (LPL) dans les deux Ctats nutritionnels par
rapport aux deux groupes témoins, quand l'activitC est exprimCe par
cellule. En conclusion, nos donnCes pennettent d'Climiner une
surproduction hépatique de lipoprotéines riches en TO chez les rats en
insuffisance rénale chronique pour expliquer leur hypertriglycériddmie,
et elles démontrent que La cause en est une diminution du catabolisme
pCriphCrique de ces lipoprotCines en raison d'un deficit en LPL,
probablement en rapport avec un Ctat de ddficience chronique en
insuline.
Chronic renal failure in humans is associated with an increase
in serum total triglyceride (TG) and very low density lipoprotein
(VLDL) concentration [1—31. The disturbed metabolism of
TG-rich lipoproteins has been generally attributed to a decrease
in several enzyme activities such as lipoprotein lipase (LPL)
according to some authors, hepatic lipase (HL) for others
[4—11], and also lecithin cholesterol acyl transferase [12, 131.
However, there still exists some controversy concerning the
depression of both lipase activities in uremic patients. The
distinction between LPL and HL activities, respectively, in
serum is difficult to verify with data. Furthermore, in vitro
methods using human tissue such as muscle cells or adipocytes
for the exploration of LPL activity may yield equivocal results,
depending essentially on the mode of expression of enzyme
activity. When reviewing the literature it becomes apparent that
only those investigators who expressed adipose tissue LPL
activity in the human per number of adipocytes have been able
to demonstrate a significant decrease in uremic patients as
compared to healthy subjects [4, 5]. However, the authors who
expressed adipose tissue LPL activity in terms of grams of
tissue weight did not find a decrease in patients with chronic
renal failure and therefore concluded that this enzyme played
only a minor role, if any, in the disturbed catabolism of TG-rich
particles in uremic humans.
The first purpose of the present experimental study in rats
was to investigate whether a decrease in adipocyte LPL activity
existed during chronic renal failure and thus whether this
enzyme played an important role in the decreased metabolism
of TG-rich particles in this setting. The second purpose of the
study was to explore the possible contribution of disturbed
energy metabolism and altered hormone status to the anomalies
of TO metabolism of chronic renal failure.
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Animal model
Male Wistar AF rats, weighing 180 to 200 g, were randomly
allocated to three groups (control rats, uremic rats, or
420
Serum TG-rich lipoproteins in uremia 421
nonuremic, sham-operated and pair-fed rats) within two experi-
mental series. The first series was studied in the fed state (1 hr
fast) and the second series alter a 16-hr fast.
Control (C) rats did not undergo a surgical intervention and
had free access to diet. Rats rendered uremic (U) by cortical
electrocoagulation of one kidney and contralateral nephrec-
tomy according to a previously described technique [14] had
also no dietary restriction. Sham-operated, diet-restricted (DR)
rats were pair-fed with their respective uremic littermates. All
animals were housed in lighted individual cages between 8 AM
and 6 PM. They had free access to water and were fed the
standard diet of the laboratory containing proteins 24%, cel-
lulose 6.5%, lipids 4.5%, glucides 45%, vitamin D 200 IU,
minerals 8% (with Ca 1.5% and P 0.95%), and water 12%
(Pietrement Laboratoire, Colombes, France).
The animals were observed during a time period of 35 days
after nephrectomy. During this experimental period the food
intake(gI24hr)was23.l l.2and22.5 0.8(mean sEM)for
U and DR rats of series 1 and 2, respectively. Despite a
comparable daily food intake, the mean body weight gain during
the experimental time period was significantly higher in DR rats
than in U rats (105.5 4.7 vs. 68.4 9.4 g for series 1 and 88.4
6.6 vs. 44.2 8.8 g for series 2).
At the end of the experimental period, the rats were de-
capitated by guillotine, without anesthesia. Blood and tissue
sampling was always done between 8 and 9 AM. Blood was
sampled in the absence of anticoagulant and sera were con-
served at —50°C for subsequent analysis. Mean serum cre-
atinine concentration was comparable in uremic rats of series 1
and 2 at the end of the experimental period and was two to three
times higher than that of control rats (221.8 19 vs. 82.2 2.6
jmoles/liter and 191 18.2 vs. 85. 2.0 molesf1iter for series
1 and 2, respectively).
Epididymal adipose tissue was removed rapidly alter sacri-
fice. One aliquot was transferred to Bouin's fixation fluid for
cell counting under the light microscope. A second aliquot was
immediately frozen in liquid nitrogen and then conserved at
— 50°C for subsequent analysis of LPL activity after tissue
delipidation with acetone and ether (AE-LPL).
Biochemical analyses
Lipoprotein lipase assay. Lipoprotein lipase activity was
assayed in acetone-ether preparations performed according to
the micromethod of Nilsson-Ehle, Tornqvist, and Bellrage [15].
Enzymatic activity was calculated according to the formula of
Nilsson-Ehle and Schotz [16] and expressed as milliunits per
gram of adipose tissue wet weight, or nanounits per number of
cells. Interassay precision as tested by the postheparin serum
assay was of 8.4% (CV) for a mean activity of 475.9 mU/ml of
serum (N = 16).
Epididymal fat celt count. Fixed specimens of epididymal
adipose tissue were dehydrated, embedded in wax, sectioned
(5-tm thick), then dewaxed, rehydrated, and stained with
hematin-eosine-safran. Fields of representatively sized cells
were photographed at known magnification. The number of
cells counted on a 10 x 18 cm photograph (final magnification
x 200) will be referred to as the number of cells observed per
high power field.
Considering the number of cells and magnification, we calcu-
lated cell diameter as indicated by Ashwell et al [17] and then
the number of cells per adipose tissue weight considering the
density of adipose tissue to be similar in the three animal groups
(d = 0.88). Adipose tissue density was measured in preliminary
studies using methanol-water solutions of varying density. No
significant difference was found between the tissues of the three
animal groups. However, it must be noted that this method may
not be sensitive enough to detect variations of tissue density
less than 0.01.
Isolation of serum lipoproteins. The lipoproteins were iso-
lated by flotation [18] at d = 1006 for VLDL or TG-rich
particles and d = 1006—1063 for LDL, in an ultracentrifuge
using a 50.3 Ti Rotor (model L8-55, Beckman Instruments,
Inc., Fullerton, California, USA).
Quantitation of hormones. Serum insulin was determined
using an INSIK-3 kit (Sorin Laboratory, Biomedica S.p.A.,
Italy), characterized by a cross-reaction of 90% with rat insulin
for a 50% inhibition of tracer binding and a cross-reaction of 7%
with proinsulin. This assay was sensitive (2.5 mU/liter) and
reproducible (intraseries CV of 5% for 26 mU/liter). Serum
glucagon was determined using a glucagon kit (Hypolab, ref.
1904, Coinsins, Switzerland). The sensitivity of the assay was
60 ng/liter and intraseries CV, 12% for 250 ng/liter.
Serum creatinine, triglycerides, and energy substrates. Cre-
atinine (kinetic method of Jaffd, Roche Diagnostica, ref. 1421),
triglycerides (enzymatic method, Boehringer ref. 24052), glu-
cose (Glucibiotrol, Biotrol, ref. 101538), lactate (lactates UV-
system, Boehringer, ref. 149993), and /3-hydroxybutyrate
(BOB) using the enzymatic method of Li et a! [19] were
quantitated on a centrifugal analyzer (Cobas Bio, Roche,
France). Nonesterified fatty acids (NEFA) extracted from
serum by chloroform were determined according to
Duncombe's method [20].
Statistical analyses and expression of results
The comparison between two groups of independent values
was made using Student's t test unless the latter was rejected by
the F test. In that case, the nonparametric U test of Mann and
Whitney was used.
Results have been expressed in terms of mean values I
SEM.
Results
Effect of chronic uremia versus chronic dietary restriction on
serum triglyceride concentration and role of acute fast
Table 1 shows that in the fed state, the concentration of
serum TG and serum TG-rich particles of U and DR rats was
lower than that of C rats. After a 16-hr fast, U rats had a
significantly higher mean serum total TG and VLDL-TG con-
centration than control rats (C or DR).
In the two experimental series, U rats had a higher serum
LDL-TG concentration than C or DR rats after a 1-hr fast which
was even more pronounced after a 16-hr fast.
Effect of chronic uremia versus chronic dietary restriction on
serum energetic substrate concentrations and role
of acute fast
Table 2 shows that U rats had a normal serum glucose
concentration in the fed state as well as alter a 16-hr fast, by
comparison with C rats. Mean serum glucose concentration of
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Table 1. Total serum and lipoprotein triglyceride concentrations
Fasting Control rats DR rats
Parameters time (N = 8) (N = 8)
Uremic rats
(N =8)
Serum TG cone, mmoleslliter 1 hr 2.24 0.17 1.80 0.14 1.79 0.11"
Serum TG-rich particles conc, mmoles/liter 1 hr 1.97 0.10 1.55 0.09a 1.49 0.05"
Serum LDL-TG conc, mmoleslliter 1 hr 0.152 0.013 0.146 0.032 0.195 0.020
Serum TG cone, mmoles/liter 16 hr 1.01 0.07 1.22 0.08 1.60 Ø19b,C
Serum VLDL-TG conc, mmoles/liter 16 hr 0.86 0.02 1.04 0.036a 1.29 0.069"
Serum LDL-TG cone, mmoleslliter 16 hr 0.078 0.019 0.123 0.026 0.244 0.066"
Abbreviations: DR, diet-restricted; TG, triglycerides; LDL, low density lipoproteins; VLDL, very low density lipoprotein.
a p < 0.05 or less for DR vs. Controls.
b P < 0.05 or less for Uremics vs. Controls.
P < 0.05 or less for Uremics vs. DR.
In all other instances, P is not significant.
Table 2. Serum energetic substrate concentrations
Fasting Control rats DR rats
Parameters time (N = 8) (N = 8)
Uremic rats
(N =8)
Serum glucose cone, mmoleslliter lhr 7.52 0.23 7.24 0.18
16 hr 7.47 0.28 8.08 0.29
7.94 0.l9C
6.76 0.27C
Serum lactate cone, mmoles/liter 1 hr 5.30 0.50 5.30 0.20
16 hr 5.42 0.54 5.68 0.52
5.90 0.60
5.25 0.84
Serum NEFA cone, pmo1es/liter 1 hr 248 38 365 45
16 hr 716 57 380 59
266 34
407 38"
Serum BOB cone, mmoles/liter 1 hr 1.21 0.05 1.40 0.11
16 hr 2.23 0.25 0.66 0.10a
1.64 0.11"
1.90 0.22C
Abbreviations: DR, diet-restricted; TG, triglycerides; NEFA, nonesterified fatty acids; BOB, /3-hydroxybutyrate.
C P < 0.05 or less for DR vs. Controls.
P < 0.05 or less for Uremics vs. Controls.
P < 0.05 or less for Uremics vs. DR.
In all other instances, P is not significant.
DR rats was also not different from that of C rats. As to serum
lactate concentration, no change was induced by the uremic
state or diet restriction, neither in the fed state nor after a 16-hr
fast. Serum NEFA concentration was similar in C, DR, and U
rats in the fed state. However, after a 16-hr fast, DR and U rats
had a significantly lower mean serum NEFA concentration than
C rats (Table 2). Serum BOB concentration was significantly
increased in U rats by comparison with C or DR rats in the fed
state, while after a 16-hr fast, U rats had a serum BOB
concentration significantly lower than C rats, but significantly
higher than DR rats.
Effect of chronic uremia versus chronic dietary restriction on
circulating insulin and glucagon and role of acute fast
Table 3 shows a striking decrease in serum insulin concentra-
tion in U rats in the fed state as well as after a 16-hr fast by
comparison with C or DR rats. Circulating glucagon concentra-
tion was higher in U rats than in C and DR rats (Table 3). A
strong correlation was found between serum glucagon and
serum creatinine values in U rats of the two series (r = 0.746,
P <0.001).
Effect of chronic uremia versus chronic dietary restriction on
epididymal LPL activity and role of acute fast
Figure 1 shows that in vitro epididymal fat LPL determined
after delipidation of adipose tissue by acetone and ether (AE-
LPL) as expressed in terms of milliunits per gram wet weight
revealed a significantly increased activity in DR rats as com-
pared to C rats and a small decrease in U rats by comparison
with C rats, which was only significant in the fed state.
The number of epididymal adipocytes observed per respec-
tive high power field under light microscopy is reported in Table
4. In the two series, a significant increase in the number of
adipocytes per high power field existed for DR and U rats (not
different between themselves) as compared to C rats. Further-
more, a significant inverse correlation could be demonstrated
between the number of adipocytes per high power field and rat
body weight at the time of sacrifice (r =
—0.719, P < 0.001); all
the animals were of comparable age.










Fed state Fast of 16 hr
Fig. 1. Epididymal AE-LPL (m U/g) of control (a), diet-restricted (a),
and uremic (E) rats in the fed state (left) and after a 16-hr fast (right).
Each group of rats is constituted of eight animals. Results are expressed
as mean + I SEM. A, B, and C represent a statistically significant
difference when comparing diet-restricted versus control rats, uremic
versus control rats, and uremic versus diet-restricted rats, respectively.
Fasting Control rats DR rats Uremic rats
Parameter time (N = 8) (N = 8) (N 8)
insulin, 1 hr 42.4 5.2 38.0 3.7 22.6 1.7Ir
mU/liter 16 hr 18.5 2.0 27.5 1.9 7.1 0.6
Glucagon, 1 hr l75 16 204 10 306 33b
ng/liter 16 hr 210 17 214 21 243 28
Abbreviation: DR, diet-restricted.
a P < 0.05 or less for DR vs. Controls.
b P < 0.05 or less for Uremics vs. Controls.
P < 0.05 or less for Uremics vs. DR.
In all other instances, P is not significant.
Table 4. Cell number per high power field in adipose
epididymal tissue
Fasting Control rats DR rats Uremic rats
time (N = 8) (N = 8) (N = 8)
1 hr 188 19 297 27 328 i5'



















Table 3. Serum insulin and glucagon concentrations
B, C





Fig. 2. Epididymal AE-LPL (nU/106 cells) of control (U), diet-restricted
(), anduremic (U) rats in the fed state (left) and after a 16-hr fast
(right). Each group of rats is constituted of eight animals. Results are
expressed as mean + 1 SEM. A, B, and C represent a statistically
significant difference when comparing diet-restricted versus control
















Fig. 3. Relationship between serum insulin concentration (mU/liter) and
AE-LPL activity (nU/106 cells) in eight control rats (0), eight diet-
restricted rats (•), and eight uremic rats (A) in the fed state.
Discussion
The present study confirms and extends previously reported
experimental data on the hypertriglyceridemia of chronLcally




a P < 0.05 or less for DR vs. Controls.
b p < 0.05 or less for Uremics vs. Controls.
When considering the above results and expressing AE-LPL
in terms of nanounits per 106 adipocytes (instead of mU/g wet
weight of fat), we could demonstrate an important decrease of
the enzyme activity in U rats as compared to C or DR rats in the
fed as well as in the fasted state (Fig. 2). Figure 2 also indicates
that no difference was found between C and DR rats for
epididymal LPL activity when expressed per cell number.
Finally, we observed a linear relation between serum insulin
concentration and epididymal AE-LPL activity expressed per
cell number when considering all rats of the first series (r =
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deficiency of adipose tissue LPL activity at the cellular level.
In the fed state, serum TG of U rats were higher than after a
16-hr fast, indicating a probable contribution of intestinal ab-
sorption via chylomicrons. It is interesting to note that in the
fed state, mean serum TG concentration and also that of
TG-rich particles was lower in U (and also in DR) rats than in C
rats which signifies a lesser or delayed intestinal contribution to
hypertriglyceridemia in the former as compared to the latter, as
already suggested by other investigators [24].
Since the increase in serum TG-rich particles during chronic
renal failure is not due to hepatic overproduction [22, 25], it
must be linked to their diminished catabolism as evidenced by
Gregg et al [25]. This is the reason why several investigations
were devoted to lipoprotein lipase, the principal enzyme impli-
cated in TG metabolism.
Our study demonstrates that LPL activity of epididymal
adipose tissue was higher in the fed state than after a 16-hr fast,
which agrees with previous studies [26, 27]. DR rats again had
a more marked increase in enzyme activity than C or U rats.
When examining the cells of epididymal adipose tissue of U
and DR rats under the light microscope, we observed that they
had a smaller size than C rats. Since the number of adipocytes
as well as their size increase to a certain age [28] and then
become stabilized [29], we hypothesized that in the present
study the total number of adipocytes should be the same in all
animal groups of comparable age but that the adipocyte size
should vary according to the different metabolic (diet restric-
tion) or pathological (uremia) conditions. In fact, the latter two
conditions were associated with a decrease in adipose cell size
and also in total epididymal fat mass as compared to the control
state of ad-lib fed animals. Such a constellation results in an
increase in the number of adipocytes per grams of tissue weight.
However, the real working possibilities of adipocytes can
only be appreciated when expressing their activity either in
terms of function at the cellular level or at the level of total fat
mass. In the DR rats of the present study, LPL activity was
significantly increased when expressed per gram of tissue
weight as compared to C animals but was identical for both
animal groups when expressed per number of cells. The meta-
bolic performance of adipose tissue was thus intact in both
animal groups, In contrast, LPL activity of uremic rats, when
expressed per gram of tissue weight was not different from that
of C rats whereas it was markedly diminished when expressed
per number of cells. Thus, the metabolic performance of
adipose tissue and its clearance capacity were significantly
altered in the uremic state when assuming that epididymal fat
was representative of total adipose tissue in those rats.
In our opinion, this notion is important since it allows
reconciliation of discrepancies between several studies of the
literature that could be reduced to a simple problem of expres-
sion of the results. Bagdade et al [22] expressed LPL activity
per milligram of tissue and found an adipose tissue activity in
uremic rats comparable to that of control rats. This finding led
them to conclude erroneously that there was probably no
quantitative defect of LPL activity contributing to the increase
in serum TG. In humans, the only two studies that reported
LPL activity of uremic adipose tissue expressed per number of
cells led to the conclusion of a significantly decreased activity
when compared to that of control subjects [4, 5].
Such a cellular LPL deficiency in uremic rats can alone
explain the increased serum TG-rich particle concentrations.
However, it does not exclude a functional abnormality of the
enzyme as suggested by others [30, 31]. In addition, LPL
deficiency by limiting triglyceride deposition in adipose tissue
could be involved in the poor nutritional state of chronic renal
failure since uremic rats had a lesser weight gain than their diet-
restricted counterparts after a comparable food intake. Whether
such a mechanism, as a direct or indirect consequence of the
insulin deficiency state, plays an important role in uremic
wasting cannot be solved, however, on the basis of the present
data. Further experiments including chronic insulin supplemen-
tation and determinations of growth and cell energy regulating
hormones are required to evaluate the respective roles of the
different factors potentially involved in uremic malnutrition.
Concerning the orientation of energy metabolism in the
uremic organism, it must be noted that all serum analyses were
performed after decapitation of the animals to eliminate the
influence of stress and anesthesia [32]. In the fed state the
observed insulin deficiency associated with normal NEFA and
increased BOB concentrations points to a preferential hepatic
use of NEFA for ketone body production in U rats instead of
TG synthesis since insulin regulates the activity of both path-
ways [33, 34]. The absence of an increase in BOB formation
during prolonged fast can be explained by the reduced fat mass
in uremia associated with a decreased peripheral production of
NEFA as indicated by low serum NEFA concentration.
The metabolic orientation of DR rats was similar to that of C
rats in the fed state and disturbed after a 16-hr fast, but in a way
different from that of U rats, that is, higher serum insulin
concentration and lower serum NEFA and BOB concentrations
when compared to C rats. This behavior could partially be due
to the difficulty to maintain DR rats within a time schedule of
fast similar to that of other rats. This appears to be a severe
limitation of the use of DR animals as controls when studying
the utilization of energetic substrates.
The above-described metabolic reorientation of the uremic
organism cannot lead to a hepatic overproduction of TG respon-
sible of the increase in TG-rich lipoproteins. In contrast, the
insulin deficiency must be at least partially responsible for the
observed decrease in adipocyte LPL activity as suggested by
the positive relation between AE-LPL at the cellular level and
serum insulin, in line with the well-known fact that insulin
stimulates LPL synthesis [26, 35—371. Despite the fact that
adipose tissue LPL represents only 54% of total body enzyme
activity in fed (adult) rats and only less than 20% in starved rats
[38], it is reasonable to hypothesize that not only adipose but
whole body LPL activity is diminished during hypoinsulinemia
leading thereby to an impaired clearance of TG-rich
lipoproteins. Thus, the decrease in LPL activity should also be
of utmost importance in the pathogenesis of the hypertriglycer-
idemia in uremia.
Whether the high circulating immunoreactive glucagon levels
may in addition play a role in the hypertriglyceridemia of
chronic renal failure remains speculative since in uremia much
of the measured hormone may be biologically inactive [39].
In conclusion, the present study confirms the existence of an
adipose tissue LPL deficiency in chronic experimental uremia
at least when assuming that epididymal fat is representative of
total adipose tissue of the organism. This data strongly suggest
that the decreased metabolic capacities of adipose tissue con-
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tribute in an important manner to the impaired catabolism of
TG-rich particles in uremia. The cause of such an enzyme
deficiency in uremic animals cannot be attributed to their
diminished nutritional state but appears to be related to the
diminution of circulating insulin. Thus, the observed distur-
bances of carbohydrate metabolism including disturbed levels
of glucoregulatory hormones represent a key factor for the lipid
anomalies of experimental chronic renal failure.
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